307 related articles for article (PubMed ID: 24423476)
21. Primary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stents.
Chan YC; Cheng SW; Ting AC; Cheung GC
J Vasc Surg; 2014 Feb; 59(2):384-91. PubMed ID: 24461862
[TBL] [Abstract][Full Text] [Related]
22. PRELUDE Prospective Study of the Serranator Device in the Treatment of Atherosclerotic Lesions in the Superficial Femoral and Popliteal Arteries.
Holden A; Hill A; Walker A; Buckley B; Merrilees S; Nowakowski P; Krzanowski M; Brodmann M
J Endovasc Ther; 2019 Feb; 26(1):18-25. PubMed ID: 30580697
[TBL] [Abstract][Full Text] [Related]
23. Impact of IVUS-Derived Vessel Size on Midterm Outcomes After Stent Implantation in Femoropopliteal Lesions.
Miki K; Fujii K; Tanaka T; Yanaka K; Yoshihara N; Nishimura M; Sumiyoshi A; Horimatsu T; Imanaka T; Fukunaga M; Akahori H; Masuyama T; Ishihara M
J Endovasc Ther; 2020 Feb; 27(1):77-85. PubMed ID: 31948376
[No Abstract] [Full Text] [Related]
24. Meta-Analysis-Derived Benchmarks of Patency and Target Lesion Revascularization of Percutaneous Balloon Angioplasty from Prospective Clinical Trials of Symptomatic Femoropopliteal In-Stent Restenosis.
Shammas NW; Jones-Miller S; Lemke J
J Vasc Interv Radiol; 2016 Aug; 27(8):1195-203. PubMed ID: 27350033
[TBL] [Abstract][Full Text] [Related]
25. Nitinol self-expanding stents vs. balloon angioplasty for very long femoropopliteal lesions.
Armstrong EJ; Saeed H; Alvandi B; Singh S; Singh GD; Yeo KK; Anderson D; Westin GG; Dawson DL; Pevec WC; Laird JR
J Endovasc Ther; 2014 Feb; 21(1):34-43. PubMed ID: 24502482
[TBL] [Abstract][Full Text] [Related]
26. Intravascular ultrasound measurements after drug-eluting stent placement in femoropopliteal lesions: determining predictors of restenosis.
Mori S; Hirano K; Nakano M; Muramatsu T; Tsukahara R; Ito Y; Ishimori H
J Endovasc Ther; 2015 Jun; 22(3):341-9. PubMed ID: 25862363
[TBL] [Abstract][Full Text] [Related]
27. Drug-Coated Balloons for Complex Femoropopliteal Lesions: 2-Year Results of a Real-World Registry.
Schmidt A; Piorkowski M; Görner H; Steiner S; Bausback Y; Scheinert S; Banning-Eichenseer U; Staab H; Branzan D; Varcoe RL; Scheinert D
JACC Cardiovasc Interv; 2016 Apr; 9(7):715-24. PubMed ID: 27056311
[TBL] [Abstract][Full Text] [Related]
28. Excimer laser with adjunctive balloon angioplasty and heparin-coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve-month results from the SALVAGE study.
Laird JR; Yeo KK; Rocha-Singh K; Das T; Joye J; Dippel E; Reddy B; Botti C; Jaff MR
Catheter Cardiovasc Interv; 2012 Nov; 80(5):852-9. PubMed ID: 22422738
[TBL] [Abstract][Full Text] [Related]
29. Lower Extremity Revascularization Using Optical Coherence Tomography-Guided Directional Atherectomy: Final Results of the EValuatIon of the PantheriS OptIcal COherence Tomography ImagiNg Atherectomy System for Use in the Peripheral Vasculature (VISION) Study.
Schwindt AG; Bennett JG; Crowder WH; Dohad S; Janzer SF; George JC; Tedder B; Davis TP; Cawich IM; Gammon RS; Muck PE; Pigott JP; Dishmon DA; Lopez LA; Golzar JA; Chamberlin JR; Moulton MJ; Zakir RM; Kaki AK; Fishbein GJ; McDaniel HB; Hezi-Yamit A; Simpson JB; Desai A
J Endovasc Ther; 2017 Jun; 24(3):355-366. PubMed ID: 28393673
[TBL] [Abstract][Full Text] [Related]
30. High dose-rate brachytherapy for the treatment of lower extremity in-stent restenosis.
Ho KJ; Devlin PM; Madenci AL; Semel ME; Gravereaux EC; Nguyen LL; Belkin M; Menard MT
J Vasc Surg; 2017 Mar; 65(3):734-743. PubMed ID: 27986482
[TBL] [Abstract][Full Text] [Related]
31. 12-Month Results From the First-in-Human Randomized Study of the Ranger Paclitaxel-Coated Balloon for Femoropopliteal Treatment.
Steiner S; Willfort-Ehringer A; Sievert H; Geist V; Lichtenberg M; Del Giudice C; Sauguet A; Diaz-Cartelle J; Marx C; Ströbel A; Schult I; Scheinert D;
JACC Cardiovasc Interv; 2018 May; 11(10):934-941. PubMed ID: 29730375
[TBL] [Abstract][Full Text] [Related]
32. Endovascular brachytherapy using liquid Beta-emitting rhenium-188 for the treatment of long-segment femoropopliteal in-stent stenosis.
Werner M; Scheinert D; Henn M; Scheinert S; Bräunlich S; Bausback Y; Friedenberger J; Schuster J; Hertting K; Piorkowski M; Rosner C; Schmidt A; Ulrich M; Gutberlet M
J Endovasc Ther; 2012 Aug; 19(4):467-75. PubMed ID: 22891824
[TBL] [Abstract][Full Text] [Related]
33. Incidence and the clinical impact of stent fractures after primary stenting for TASC C and D femoropopliteal lesions at 1 year.
Davaine JM; Quérat J; Guyomarch B; Brennan MÁ; Costargent A; Chaillou P; Patra P; Gouëffic Y
Eur J Vasc Endovasc Surg; 2013 Aug; 46(2):201-12. PubMed ID: 23773773
[TBL] [Abstract][Full Text] [Related]
34. French multicenter experience with the GORE TIGRIS Vascular Stent in superficial femoral and popliteal arteries.
Sibé M; Kaladji A; Boirat C; Cardon A; Chaufour X; Bossavy JP; Saint-Lebes B
J Vasc Surg; 2017 May; 65(5):1329-1335. PubMed ID: 28222987
[TBL] [Abstract][Full Text] [Related]
35. Histopathological Evidence of Adventitial or Medial Injury Is a Strong Predictor of Restenosis During Directional Atherectomy for Peripheral Artery Disease.
Tarricone A; Ali Z; Rajamanickam A; Gujja K; Kapur V; Purushothaman KR; Purushothaman M; Vasquez M; Zalewski A; Parides M; Overbey J; Wiley J; Krishnan P
J Endovasc Ther; 2015 Oct; 22(5):712-5. PubMed ID: 26208657
[TBL] [Abstract][Full Text] [Related]
36. Long-term outcomes with Jetstream atherectomy with or without drug coated balloons in treating femoropopliteal arteries: A single center experience (JET-SCE).
Shammas NW; Shammas GA; Jones-Miller S; Shammas WJ; Bou-Dargham B; Shammas AN; Banerjee S; Rachwan RJ; Daher GE
Cardiovasc Revasc Med; 2018 Oct; 19(7 Pt A):771-777. PubMed ID: 30420096
[TBL] [Abstract][Full Text] [Related]
37. Retrograde Popliteal Access to Percutaneous Peripheral Intervention for Chronic Total Occlusion of Superficial Femoral Arteries.
Dumantepe M
Vasc Endovascular Surg; 2017 Jul; 51(5):240-246. PubMed ID: 28595481
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of Cutting Balloon Angioplasty for Chronic Total Occlusion of Femoropopliteal Arteries.
Shimada Y; Kino N; Tonomura D; Yamanaka Y; Nishiura S; Yano K; Ito K; Yoshida M; Tsuchida T; Fukumoto H
Ann Vasc Surg; 2019 Jul; 58():91-100. PubMed ID: 30769058
[TBL] [Abstract][Full Text] [Related]
39. Paclitaxel-Coated Balloon vs Uncoated Balloon Angioplasty for Treatment of In-Stent Restenosis in the Superficial Femoral and Popliteal Arteries: The COPA CABANA Trial.
Tepe G; Schroeder H; Albrecht T; Reimer P; Diehm N; Baeriswyl JL; Brechtel K; Speck U; Zeller T
J Endovasc Ther; 2020 Apr; 27(2):276-286. PubMed ID: 32096451
[No Abstract] [Full Text] [Related]
40. Nitinol stent implantation in the superficial femoral artery and proximal popliteal artery: twelve-month results from the complete SE multicenter trial.
Laird JR; Jain A; Zeller T; Feldman R; Scheinert D; Popma JJ; Armstrong EJ; Jaff MR;
J Endovasc Ther; 2014 Apr; 21(2):202-12. PubMed ID: 24754279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
